Zobrazeno 1 - 10
of 89
pro vyhledávání: '"M.G. Rajanandh"'
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 12, Iss , Pp 73-77 (2018)
Objective: To compare a fixed-dose combination (FDC) of Rifampicin 450 mg, Isoniazid 300 mg, Pyrazinamide 1500 mg and Ethambutol 800 mg (usual care group) and regimen of Rifampicin 200 mg, Isoniazid 300 mg and piperine 10 mg along with Pyrazinamide 1
Externí odkaz:
https://doaj.org/article/28376f7a9844423f80db1c203a51a0ba
Autor:
M.G. Rajanandh, Julius Xavier Scott, Janga Srikar Reddy, Jerlin Mariam Raju, M. Kaniarivi, Katta Ravali Raj
Publikováno v:
Journal of Cancer Research and Practice, Vol 5, Iss 1, Pp 20-23 (2018)
Background: Even though the use of complementary and alternative medicines (CAMs) is thought to be more prevalent among pediatric cancer patients, no studies have been reported on a South Indian population. Objectives: This study aimed to investigate
Externí odkaz:
https://doaj.org/article/2d854e681dba4897968c81232ddbb59a
Autor:
P. Aravind, S. Adikrishna, S. Sarvesh, R.P. Ragupathi, G. Rajesh, R. Rema Premi, M.G. Rajanandh
Publikováno v:
Journal of Medical Sciences. 22:73-77
Publikováno v:
Amino Acids. 53:575-585
Autism spectrum disorders (ASD) are an emerging health problem worldwide. So far, no definite cure for ASD exists. L-Carnosine is an amino acid containing β-alanine and L-histidine which has been proposed to have neuroprotective, antioxidant and ant
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Clinical Therapeutics. 42:e250-e258
Purpose Pyridoxine hydrochloride and magnesium sulfate (pyridoxine-Mg) have been used for the management of autism spectrum disorder (ASD). We present a case report of 2 children with ASD who were administered pyridoxine-Mg for 2 months. Methods The
Autor:
Elangovan Sandhiya, Meeran Sahina Begum, M.G. Rajanandh, Santhosh Kumar Sanchana, Mathivanan Koushik Muthu Raja
Publikováno v:
Asian Journal of Scientific Research. 13:126-131
Publikováno v:
Journal of Research in Pharmacy Practice, Vol 9, Iss 3, Pp 155-157 (2020)
Journal of Research in Pharmacy Practice
Journal of Research in Pharmacy Practice
Challenges faced by non-COVID-19 patients with chronic illness are limitless during the lockdown period. These patients are mostly immunocompromised and vulnerable to infection. The worst affected would be chronic disease patients with lower househol
Publikováno v:
Journal of Pharmacology and Toxicology. 14:9-17
Autor:
Arunagiri Abirami, Sivaguru Paramesh Ahalya, Jamindar Ganesh Bhuvaneswari, M.G. Rajanandh, Rajendran Anjali
Publikováno v:
Drugs & Therapy Perspectives. 35:77-85
First-line controller combination therapy for the management of asthma is a low-dose inhaled corticosteroid (LD-ICS) + a long-acting β-agonist (LABA), and second-line options are a LD-ICS + a leukotriene receptor antagonist (LTRA), LD-ICS + sustaine